A double-blind, randomized controlled trial exploring the efficacy of frequency lowering hearing aids in patients with high-frequency hearing loss
Auris Nasus Larynx Sep 06, 2020
Yakunina N, et al. - In this first, relevant, double-blind, randomized controlled trial, researchers sought to compare the effectiveness of linear frequency transposition (LFT) hearing aids (HAs) to those of compression-type HAs in patients with high-frequency hearing loss (HFHL). In total, 103 participants were randomized into three groups: conventional HAs featuring wide dynamic range compression (control group); HAs featuring LFT (LFT group); and HAs employing both LFT and wide dynamic range compression of high frequencies (combined group). According to results, LFT offered no additional benefit to patients with HFHL over conventional amplification and users preferred conventional HAs featuring wide dynamic range compression.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries